New registry aims to unlock secrets of myasthenia gravis
NCT ID NCT03792659
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is creating a registry of 800 adults with myasthenia gravis at Yale University. Participants donate blood and stool samples, which will be used for future research to better understand the disease. The goal is to collect data and samples to support many research projects down the line.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this registry will provide a valuable resource for future studies that could improve understanding of myasthenia gravis.
- What could go wrong
- This is an observational registry, not a treatment trial. It does not test any therapy, so it cannot directly lead to new treatments.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYASTHENIA GRAVIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Yale-New Haven Hospital
RECRUITINGNew Haven, Connecticut, 06510, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can tracking daily life unlock myasthenia gravis mysteries?
- Can engineered immune cells tame a debilitating autoimmune disease?
- Can pregnancy and neurological disease coexist safely? a new registry seeks answers
- Can DNA reveal the roots of a rare muscle disease?
- Can a simple blood test unlock the secrets of brain autoimmune diseases?
- Could a new drug help keep myasthenia gravis symptoms at bay?